SCHEMBL10606169

SCHEMBL10606169

O=C(OCc1ccccc1)N1CCc2c(cc(O)c(OCc3ccccc3)c2Cl)C(c2ccc(OCc3ccccc3)cc2)C1.O=P(O)(OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 7/20 0.40
▸ DRD1 P21728 6/20 0.38
▸ DRD2 P14416 4/20 0.38
▸ MTOR P42345 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ THPO P40225 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ GMNN O75496 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10600866 0.94 PTGDR2 (0.44) PTGDR2DRD1DRD2MTORCYP1A2
SCHEMBL10606164 0.87 PTGDR2 (0.41) PTGDR2S1PR5NPC1RAB9ACHRNB2
SCHEMBL9157251 0.84 YAP1 (0.44) DRD1DRD2MTORCYP1A2CYP3A4
SCHEMBL9162086 0.77 DRD1 (0.52) DRD1DRD2MTORCYP1A2CYP3A4
SCHEMBL10603185 0.76 GHSR (0.42) PTGDR2DRD1DRD2MTORTHPO
SCHEMBL9160083 0.74 YAP1 (0.44) ALOX15LMNAGAANPC1RAB9A
SCHEMBL9158709 0.73 YAP1 (0.44) S1PR5
SCHEMBL9161002 0.70 YAP1 (0.44) ALOX15LMNAGAANPC1RAB9A
SCHEMBL10866767 0.69 NPC1 (0.36) DRD1DRD2S1PR5NPC1RAB9A
SCHEMBL9165947 0.68 ESR2 (0.39) DRD1DRD2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0167204-B1 METHOD FOR IMPROVING THE ABSORPTION AND EFFECTIVENESS OF A CATECHOLAMINE COMPOUND SIMES S.p.A. Società Italiana Medicinali e Sintetici (IT) 1989-09-27 — — EP disclosed
US-4673671-A CONVERSION TO MONO O-PHOSPHATE ESTER SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) 1987-06-16 — — US disclosed
Send feedback